Print ISSN:-2395-1354

Online ISSN:-2395-1362

CODEN : IJOSHC

Article History

Received : 08-12-2021

Accepted : 08-01-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 384

PDF Downloaded: 173


Secondary malignant transformation of giant cell tumor of the first metatarsal presenting as a fungating cauliflower like mass- A rare case report


Full Text PDF


Case Report

Author Details : Kapil Lalwani, Abhishek T Shinde*, Rajendra N Shewale

Volume : 8, Issue : 1, Year : 2022

Article Page : 91-95

https://doi.org/10.18231/j.ijos.2022.016



Suggest article by email

Get Permission

Abstract

Introduction: Giant cell tumor (GCT) is the most commonly occurring benign bone tumor. It occurs more commonly in the third decade of life and is slightly more common in females. The knee joint i.e. the distal femur as well as proximal tibia account for most number cases followed by the distal end of radius. The occurrence in foot is rare and usually occurs in the younger age group. The progression in foot is usually accelerated and is masked by vague symptoms and boring type of foot pain. Malignant transformation is rare.
Case Report: In our case the 38 years female patient had GCT of the first metatarsal which later progressed to a secondary malignancy involving the ipsilateral inguinal and femoral lymph nodes. This was later managed by performing a Syme’s amputation along with the involved lymph node dissection.
Conclusion: In our single case we noted these salient features of GCT which has a high rate of recurrence, is locally aggressive and has potential for malignant transformation.
 

Keywords: Giant cell tumor, Metatarsal, Malignant, Amputation.



How to cite : Lalwani K, Shinde A T, Shewale R N, Secondary malignant transformation of giant cell tumor of the first metatarsal presenting as a fungating cauliflower like mass- A rare case report. Indian J Orthop Surg 2022;8(1):91-95


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.